Contact – +1-276-477-5910
 Email – info@supplydemandmarketresearch.com

Home >> Latest Reports

 LATEST REPORTS


Asia Pacific Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Count...

Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.1% annually with a total addressable market cap of $584.2 billion over 2020-2030 amid the COVID-19 pandemic. Highlighted with 38 tables and 65 figures, this 133-page report “Asia Pacific Active Pharmaceutical Ingredients (...

 2020-06-30 |  Healthcare and Social Assistance


Europe Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Tr...

Europe active pharmaceutical ingredients (API) market reached $42.41 billion in 2019 and will grow by 7.6% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic. Highlighted with 41 tables and 66 figures, this 133-page report “Europe Activ...

 44008 |  Healthcare and Social Assistance


North America Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Coun...

North America active pharmaceutical ingredients (API) market is expected to grow by 5.7% annually in the forecast period and reach $101.03 billion by 2026 driven by the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic. Highlighted with 31 tables and 62 figures, this 128-...

 44008 |  Healthcare and Social Assistance


Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Tre...

Global active pharmaceutical ingredients (API) market will reach $293.5 billion by 2026, growing by 7.2% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic. Highlighted with 91 tables and 99 figures, this 190-page report “Global Active ...

 44008 |  Healthcare and Social Assistance


Global Pertussis Vaccine Consumption Market Professional Survey Report 2019

According to XYZResearch's analysis,the Pertussis Vaccine revenue had reached about 5147.12 million USD in 2016 from 4026.75 million USD in 2012 in global, with the CAGR of 6.33%. Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: Whole-cell vaccine...

 Jun. 2020 |  Pharma & Healthcare


Global Pertussis Vaccine Consumption Sales Market Report 2020 by Manufacturer, Region, Type and Application

According to XYZResearch's analysis, the Pertussis Vaccine revenue had reached about 5147.12 million USD in 2016 from 4026.75 million USD in 2012 in global, with the CAGR of 6.33%. Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: Whole-cell vaccin...

 Jun. 2020 |  Pharma & Healthcare


Global Pertussis Vaccine Consumption Market by Manufacturers, Regions, Type and Application, Forecast to 2025

According to XYZResearch's analysis,the Pertussis Vaccine revenue had reached about 5147.12 million USD in 2016 from 4026.75 million USD in 2012 in global, with the CAGR of 6.33%. Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: Whole-cell vaccine...

 Jun. 2020 |  Pharma & Healthcare


Global Pertussis Vaccine Consumption Market Research Report 2020 by Manufacturers, Regions, Types and Applications

According to XYZResearch's analysis,the Pertussis Vaccine revenue had reached about 5147.12 million USD in 2016 from 4026.75 million USD in 2012 in global, with the CAGR of 6.33%. Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: Whole-cell vaccine...

 Jun. 2020 |  Pharma & Healthcare


Global Perphenazine Market Professional Survey Report 2019

According to XYZResearch's analysis,perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perp...

 Jun. 2020 |  Pharma & Healthcare


Global Perphenazine Sales Market Report 2020 by Manufacturer, Region, Type and Application

According to XYZResearch's analysis,perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perp...

 Jun. 2020 |  Pharma & Healthcare


x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT